$ACST There were signs from last year that my DD found showing this CaPre was not a good investment; in fact TMAO shows issues from multiple studies. The CSO was hiding the truth and mixing the facts as noted above. A learning lesson, is to review companies like $AMRN and $MTNB where the products are superior and niche. No TMAO issues, & superior executives and board members who to date have not mixed up fact or delayed data.
  • 4
  • 1